Sign in
4

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0000950170-24-112325

Director sold 29,941 shares at an average $35.32 ($1,057,460)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kersten Dirk Director 2024-10-01 Sale 10b5-1 −8,423 $35.16 $296,153 150,282 I: show line 1 in the form
Kersten Dirk Director 2024-10-02 Sale 10b5-1 −21,518 $35.38 $761,307 128,764 I: show line 2 in the form
Open-market sales · 29,941 sh · avg $35.32 · $1,057,460
Loading xslF345X05/ownership.xml…